More recently, our group demonstrated that ATG inhibited pulmonary TXNRD1 activity and significantly attenuated hyperoxic lung injury in a neonatal mouse model of BPD [9]. The gene discussed is TXNRD1; the disease is bronchopulmonary dysplasia.